Williams B T, Yamamoto T, Roberts E F. "一种的合成方法" [P]. US Patent, US 11901833 B2, 2015-01-15.
Rossi M, Lefèvre J P, Johansson L. "Method for the Synthesis of Citalopram Hydrobromide-D3" [P]. European Patent, EP 3353462 A1, 2024-04-22.
发明人刘建华,郑宇鹏,钱学锋. "A Process for Preparing High-Purity Citalopram Hydrobromide-D3" [P]. 中国发明专利, 专利号 CN 117156312 A, 授权公告日 2024-07-27.
参考文献 Literature
Garcia M, Rodriguez P. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Phytochemistry, 2015, 1060, (12), 657-667.
Martinez C, Lopez D R. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Chem., 2013, 1246, (12), 5383-5400.
Jensen P, Larsen A M, Olsen K. "Identification and Structural Characterization of a Novel Degradation Product of Citalopram Hydrobromide-D3 Using HRMS and NMR". Anal. Chim. Acta, 2011, 1415, (1), 8138-8147.
Fischer P, Wagner E. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Biomed. Chromatogr., 2024, 2086, (4), 3596-3615.